6h
Zacks.com on MSNArtivion (AORT) Reports Break-Even Earnings for Q4Artivion (AORT) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of $0.12. This compares to earnings of $0.11 per share a year ago. These figures are adjusted for ...
NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to ...
Media are invited to join Marc G. Serré, Member of Parliament for Nickel Belt, alongside Douglas Gervais, Mayor of Espanola for the ...
Beyond analysts' top -and-bottom-line estimates for TransMedics (TMDX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the ...
In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on TransMedics Group (TMDX – Research Report), with a ...
Van ECK Associates Corp grew its holdings in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 102.3% in the fourth ...
Van ECK Associates Corp raised its holdings in shares of Guardant Health, Inc. (NASDAQ:GH – Free Report) by 47.4% in the 4th ...
TransMedics Group, Inc. ("TransMedics") , a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today announced the ...
TransMedics is revolutionizing organ transplant therapy with its FDA-approved Organ Care System. See why I rate TMDX stock as ...
WHY: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of TransMedics Group, Inc. (NASDAQ: TMD ...
Analysts predict an EPS of $0.22 and revenue of approximately $109.5 million for the upcoming quarterly report. Legal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results